Skip to main content

Clinical trial GS-US-218-1227

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Multi-Center Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of GS-5806 in Hospitalized Adults with Respiratory Syncytial Virus (RSV) Infection

Cancers
Organ solid tumors
Trial status Trials closed
Investigator
Trial type
Prospective interventional
Phase Trial phase 2b
Academic trial Non
Sponsor Gilead Sciences
EudraCT Identifier 2014-002137-58
ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02135614
Last update

Follow us!

Support research

Support research

Research at the Institut Jules Bordet depends on your generosity. Make a donation today and join us in the fight against cancer.

Learn more